Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-08

Clinical Trial Update: a Chronobiological Treatment Combining Evening Melatonin and Morning Light Therapy in Idiopathic Hypersomnia: a Prospective, Double Bind, Randomized, Placebo-controlled -Trial [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind trial evaluating evening melatonin in combination with morning light therapy for Idiopathic Hypersomnia is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Idiopathic Hypersomnia | Phase 2 | Status: RECRUITING